News

A new study finds Medicare beneficiaries are facing higher deductibles and cost-sharing requirements following changes ...
GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...
This recent study underscores the fact that biomarkers serve not merely as statistical instruments but as insights into ...
A lack of training and vague, overlapping symptoms can be attributed to more than three-quarters of autoimmune patients being ...
New study results provide insight into improving heart health through behavior changes, such as taking standing breaks ...
COVID-19 vaccine proves cost-effective, especially for older adults, significantly reducing illness and hospitalizations across all age groups.
An expert discusses how phototherapy requires 2 to 3 sessions per week in specialized light booths or home units, is particularly useful for vitiligo covering more than 10% body surface area, and can ...
Prefilled syringes of Imuldosa now have the lowest wholesaler acquisition cost among all branded ustekinumab biosimilars, ...
Wegovy is the first GLP-1 drug approved to treat adults with metabolic dysfunction-associated steatohepatitis (MASH). An ...
Tonmya is the first new fibromyalgia treatment approved by the FDA in more than 15 years, providing symptom relief for at ...
To help Medicare plans better manage members with high drug expenses, Prime Therapeutics has launched an AI-driven tool to ...